Dr. Said Daneshmand, United States

Dr. Said Daneshmand is an internationally recognized fertility specialist with extensive experience in third-party reproduction.

Dr. Daneshmand serves on the boards of several surrogacy advocacy organizations. He co-developed in vitro fertilization (IVF) protocols to improve pregnancy rates, including PTEC (post-thaw extended culture), one of the most successful IVF protocols currently available. These pioneering findings were published in the internationally recognized medical journal Fertility and Sterility, for which Dr. Daneshmand also serves as a reviewer.

Dr. Daneshmand completed his fellowship and residency training at UCLA. He is board-certified in obstetrics and gynecology and subspecialty board-certified in reproductive endocrinology.

Among his achievements, Dr. Daneshmand has received numerous awards, including the Eileen Pike Medical School Valedictorian Award and the PCRS Fellowship and Practicing Physician Research Award. He served as president of the Alpha Omega Alpha Honor Society (Iota Chapter) and is a member of the Decherney Society, the American Society for Reproductive Medicine (ASRM), and the European Society of Human Reproduction and Embryology (ESHRE). Dr. Daneshmand speaks French, Spanish, and Persian.

“My patients’ strong desire to become parents is the sole driving force behind my career. I am committed to walking this sometimes difficult path with them and supporting them throughout their unique journey to parenthood. With unwavering dedication, we work together to overcome challenges and achieve this shared goal.”

Dr. Daneshmand specializes in complex IVF cases, and his research focuses on endometrial receptivity to maximize the likelihood of IVF success. Internationally recognized for his expertise in egg donation and surrogacy, he is one of the leading providers of third-party reproductive care in the United States, treating patients from more than 40 countries in 2018 alone. Dr. Daneshmand has presented his research worldwide, including numerous presentations to leading IVF specialists in China. He is known for developing and implementing advanced technologies, including NGS (next-generation sequencing), the latest and most precise technology for assessing the genetic health of embryos.